Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites.   The Bristol PA site manufacturing facility upgrades allow Abzena’s ADC client projects to seamlessly progress from discovery to commercial without technology transfer.   The Bristol site enhancements include two new GMP suites, one for small molecules, including high potency up to 100L scale, and one for conjugation, as wel...